• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

    9.655 +0.045 (+0.47%)
    Streaming Delayed Price Updated: 11:45 AM EST, Dec 8, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Intellia Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    News headline image
    These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now ↗
    Neither word has anything to do with money -- at least not yet. 
    Via The Motley Fool
    News headline image
    Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock ↗
     
    Via Benzinga
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    The widely followed growth investor made big moves as May came to a close. 
    Via The Motley Fool
    News headline image
    The 3 Best Biotech Stocks to Buy in June 2024 ↗
    Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia. 
    Via InvestorPlace
    News headline image
    Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics ↗
     
    Via Benzinga
    News headline image
    Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗
    In keeping with Cathie Wood's style, these picks are riskier than average. 
    Via The Motley Fool
    News headline image
    Why Intellia Therapeutics, Inc. Outpaced the Stock Market ↗
    Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure. 
    Via Talk Markets
    News headline image
    2 Stocks Down 30% to Buy Right Now ↗
    These stocks have plenty of catalysts ahead. 
    Via The Motley Fool
    News headline image
    Why Intellia Therapeutics Shares Are Trading Higher Monday ↗
    Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single does treatment led to... 
    Via Benzinga
    News headline image
    Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
     
    Via Benzinga
    News headline image
    Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action ↗
    On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares. 
    Via Benzinga
    News headline image
    Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗
    Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
    Via Benzinga
    Topics ETFs
    News headline image
    Is Intellia Therapeutics Stock a Buy Now? ↗
    The company's future will depend on its innovative qualities. 
    Via The Motley Fool
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    The popular growth investor keeps adding to some of her favorite falling stocks. 
    Via The Motley Fool
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year. 
    Via The Motley Fool
    News headline image
    NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗
    NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    Just Say No to Drugs: 3 Pharma Stocks to Avoid ↗
    Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. 
    Via InvestorPlace
    News headline image
    Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗
    The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
    Via InvestorPlace
    News headline image
    3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
    Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
    Via InvestorPlace
    News headline image
    Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week. ↗
    These two stocks could be ripe for a rebound. 
    Via The Motley Fool
    News headline image
    Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗
    These stocks, a bargain today, are players to hold on to for the long term. 
    Via The Motley Fool
    Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
    --News Direct-- 
    Via News Direct
    News headline image
    ARKK’s Tech Bets: Over 500k Roblox Shares Purchased, 1.24M Robinhood Shares Sold ↗
    Cathie Wood's ARK Innovation ETF had an active trading week, with notable transactions including the purchase of over 500k Roblox shares and the sale of 1.247 million shares of Robinhood Markets. 
    Via Talk Markets
    Topics ETFs
    News headline image
    Better Cathie Wood Stock: Moderna vs. Intellia ↗
    Moderna and Intellia have declined in the double digits over the past year. 
    Via The Motley Fool
    News headline image
    Hot Stocks: The 3 Best Opportunities for Investing in Biotech ↗
    Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now. 
    Via InvestorPlace
    News headline image
    3 Stocks That Could Be the Next Big Thing in Gene Editing ↗
    Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. 
    Via InvestorPlace
    News headline image
    Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst ↗
    2024 could see the start of its first late-stage clinical trials. 
    Via The Motley Fool
    News headline image
    A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now ↗
    The futures for these two beaten-down stocks could be brighter than their recent pasts. 
    Via The Motley Fool
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month. 
    Via The Motley Fool
    News headline image
    Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed ↗
    On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.